Rafael Becerril Arreola

Rafael Becerril Arreola is an assistant professor of marketing and the Business Partnership Foundation dean’s fellow at the Moore School of Business. He applies his training in business, economics, and engineering to study the general and disparate effects of consumer socioeconomics and technology on consumer behavior, business decisions, and market outcomes. With his research, Arreola seeks to facilitate the design, optimization, implementation, and evaluation of managerial decisions and public policies. He received a Ph.D. in management with a concentration in quantitative marketing and economics from the University of California, Los Angeles, a master’s degree in electrical engineering from the University of Toronto, and an undergraduate degree in electrical and computer engineering from ITESM campus Toluca.

Erick Sager

Erick Sager is a senior economist at the Federal Reserve Board of Governors. His research focuses on the effects of firm competition, inflation, international trade, and inequality on the macroeconomy. Prior to joining the Federal Reserve Board, he was a research economist in the Division of Price and Index Number Research at the U.S. Bureau of Labor Statistics, a visiting assistant professor of economics at Johns Hopkins University, and a research analyst at the Federal Reserve Bank of Minneapolis. Sager received his Ph.D. from the University of Minnesota.

Luca Maini

Luca Maini is an assistant professor of economics in the Department of Economics at the University of North Carolina in Chapel Hill and a research fellow at the Cecil G. Sheps Center for Health Services Research. His research focuses on competition in pharmaceutical markets, with an emphasis on the interaction between government regulation and firm strategy. Maini received his Ph.D. in economics from Harvard University and his B.A. in economics and B.S. in mathematics from the University of Chicago.

Josh Feng

Josh Feng is an assistant professor in the Department of Entrepreneurship and Strategy at the University of Utah’s David Eccles School of Business. His research focuses on the organization of prescription drug markets, intellectual property, and the direction innovation. Feng received his Ph.D. in economics and A.B. in applied mathematics from Harvard University.

Ginger Jin

Ginger Zhe Jin is a professor of economics at the University of Maryland and research associate at the National Bureau of Economic Research. Most of her research focuses on information asymmetry among economic agents and how to provide information to overcome the information problem. Her research has been published in leading economics, management, and marketing journals, with support from the National Science Foundation, the Net Institute, and the Sloan Foundation. She was the director of the Federal Trade Commission’s Bureau of Economics from January 2016 to July 2017 and an Amazon scholar from January 2019 to May 2020. She received her Ph.D. in economics from the University of California, Los Angeles in 2000.

Liad Wagman

Liad Wagman is a professor of economics and the John and Mae Calamos Dean of the Stuart School of Business at the Illinois Institute of Technology. He is also an affiliate professor of economics at the Lewis College at the Illinois Institute of Technology and a competition fellow at the Data Catalyst Institute. Wagman is an economist who studies the regulation of digital markets, including policies concerning privacy, antitrust, entrepreneurship, and innovation. From 2020 to 2022, he served as senior economic and technology advisor at the U.S. Federal Trade Commission’s Office of Policy Planning. Wagman received his Ph.D. and M.A. in economics from Duke University and his M.S. in computer science from Stanford University.

Fern Ramoutar

Fern Ramoutar is a Ph.D. candidate studying economics at the University of Chicago’s Booth School of Business. She is an applied microeconomist whose research focuses on economic and racial inequality, food insecurity, urban economics, and political economy. Ramoutar holds a B.A. in economics and international relations from the University of Toronto and an M.A. in economics from the University of British Columbia.

Emily Ellis

Emily Ellis is a Ph.D. candidate in social work at the University of Chicago. Her research examines how social insurance and means-tested programs affect families with caregiving needs. Her dissertation is a mixed-methods study that explores how family structure and public benefits affect caregiving arrangements for older adults. Ellis has a B.S. in economics and a B.A. in women’s, gender, and sexuality studies from American University, and an A.M. in social service administration from the University of Chicago.

Marina Gorzig

Marina Mileo Gorzig is an applied microeconomist whose research focuses on social inequalities, particularly discrimination in the labor market and health disparities. Gorzig is a researcher at Mathematica and a member of the 2022–2023 cohort at the Opportunity and Inclusive Growth Institute of the Minneapolis Federal Reserve. Previously, Gorzig was an assistant professor at St. Catherine University, where she engaged in numerous collaborative research projects with students focusing on discrimination in policing, housing, and the labor market, and taught a wide range of courses in economics and public policy. She received her Ph.D. in public policy from Duke University, her M.S. in economics from Tufts University, and her B.A. in economics from Earlham College.

Thomas Hwang

Thomas Hwang is the founder of the Cancer Innovation and Regulation Initiative at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, and a resident physician in urological surgery at Brigham and Women’s Hospital/Harvard Medical School. His research focuses on the regulation, reimbursement, and clinical development of new medicines and health technologies. His work has contributed to important policy and regulatory reforms in the United States and Europe, and. has been published in Science, New England Journal of Medicine, JAMA, Lancet, and Lancet Oncology. He received his M.D. from Harvard Medical School and his A.B. from Harvard College.